Indikasi : Anak–anak di atas 2 tahun dan dewasa yang memiliki risiko tinggi terhadap infeksi Neisseria meningococci, khususnya grup A, C, Y dan W135. Orang yang bepergian atau tinggal di daerah dengan risiko tinggi seperti Sub-Saharan Afrika (daerah epidemic meningococcal grup A, C, Y dan W135). Orang yang terpapar oleh meningococcal grup A, C, Y dan W135, seperti di pusat penelitian dan tempat produksi vaksin. Orang yang bepergian atau tinggal di daerah wabah meningitis sesuai dengan rekomendasi dari WHO, CDC atau Kementerian Kesehatan.
Established in 1997 by 7 founding fathers from different expertise and professional, PT MERSIFARMA TIRMAKU MERCUSANA, further shortly called MERSI, meaning: Manufacturing drugs Equlivalent Research Standard International. With "PRIMA SETIA" guidelines as a ...
During the establishment of the company, development strategy has been intensively carried thorough to other pharmaceutical company, develop a brands of superior product and reach international market. Mersi becomes an integrated healthcare products company...
With support from more than 644 factory employees, including 98 supporting personnels and 460 marketing personnels in all over Indonesia. Mersi continues to grow into one of the pharmaceutical industry to be reckoned with. Uniquely, the Mersifarma's team ...